Length of Stay Completed Phase 3 Trials for Oxaliplatin (DB00526)

IndicationStatusPhase
DBCOND0036364 (Length of Stay)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01080547Study Comparing Conventional and Fast Track Multi-Discipline Treatment Interventions for Colorectal CancerTreatment